Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort studyArticle Published on 2022-09-012022-11-16 Journal: PLoS Medicine [Category] SARS, 변종, [키워드] 95% confidence interval age Alpha variant Analysis BNT162b2 mRNA calculated CIs cohort study Comorbidity contagious coronavirus 2 COVID-19 COVID-19 hospitalization Delta delta variant Denmark dose doses Effectiveness estimate geographical region group groups Hospitalization Infection mRNA-1273 nonrandomized study Occurrence omicron provided Regression model respiratory SARS-CoV-2 SARS-COV-2 infection Sex short-lived sustained the vaccine uninfected unique vaccinated individuals vaccination Vaccination Status vaccine dose variant variants waned waning immunity was obtained was used [DOI] 10.1371/journal.pmed.1003992 PMC 바로가기
Functional profiling of Covid 19 vaccine candidate by flow virometryArticle Published on 2022-09-012022-10-05 Journal: Vaccine [Category] SARS, 변종, 진단, 치료기술, [키워드] Antigen antigenicity clinical trial complex Covid 19 vaccine detect discovery phase expressed expression levels Flow virometry MONITOR monoclonal antibodies process improvement Protein provided required S protein S protein stability SARS-CoV-2 spike SARS-CoV-2 spike protein selected sequence the S protein the vaccine utility vaccine candidate Vaccine development Vaccines vesicular stomatitis virus virus inactivation VSV VSV virus [DOI] 10.1016/j.vaccine.2022.08.006 [Article Type] Article
COVID-19 vaccination in people with multiple sclerosis, real-life experienceResearch article Published on 2022-09-012022-10-05 Journal: Clinical neurology and neurosurgery [Category] COVID19(2023년), SARS, 임상, [키워드] acute respiratory syndrome Adverse adverse events age approved association BNT162b2 BNT162b2 vaccine ChAdOx1 nCoV-19 Clinical data Cohort common adverse event Complete Complication coronavirus Coronavirus disease 2019 COVID-19 COVID-19 infection COVID-19 vaccination COVID-19 vaccine demographic disease dose event fatigue females Fever first dose General population increased risk Infection injection investigated Kuwait mRNA multiple sclerosis National objective Occurrence Pain Patient Pfizer-BioNTech questionnaire reduce Registered reported resolved Result risk Safe SARS-CoV-2 subjects Symptom Symptoms the vaccine Therapies therapy treated vaccination Vaccine virus were recorded WhatsApp worsening [DOI] 10.1016/j.clineuro.2022.107374 [Article Type] Research article
A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment.Review Published on 2022-09-012022-10-05 Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] SARS, 변종, 비임상, 유전자 메커니즘, 임상, 진단, 치료법, 치료제, [키워드] addition administration antibody Antiviral antiviral agent antiviral drug approved cellular combined treatment Complex network Complication conditions COVID-19 COVID-19 infection COVID-19 vaccinations critical COVID-19 patient Cytokine release syndrome Delta determinant effective Efficacy extrinsic healthy humoral immune memory immune system immunogenicity Immunological response immunomodulators immunomodulatory drug indicate Inflammation Inflammatory response intrinsic lactoferrin maintain mechanisms Medicine monoclonal antibody natural Occurrence offer omicron parameter parameters pathogen PROTECT reduce relative contribution Remdesivir SARS-CoV-2 SARS-CoV-2 variants Side effects specific disease Stage the vaccine tissue tissue homeostasis transmissible variant Treatment treatment trial vaccination Vaccine vaccine responses Vaccine-induced immunity WHO widespread World Health Organization [DOI] 10.1016/j.biopha.2022.113499 [Article Type] Review
COVID-19 mRNA vaccine effectiveness against hospitalisation and death in veterans according to frailty status during the SARS-CoV-2 delta (B.1.617.2) variant surge in the USA: a retrospective cohort studyResearch article Published on 2022-09-012022-10-05 Journal: The Lancet. Healthy longevity [Category] SARS, 변종, 임상, [키워드] 95% CI Affair age Antigen assessment B.1.617.2 baseline category Cemetery center clinical COVID-19 COVID-19 vaccination COVID-19 vaccine death Department diagnosed education effective Effectiveness finding frailty funding Future hazard ratio hospitalisation information males medical condition Miami mRNA vaccine Odds ratio Older Patient populations positive Positive test preventing infection Primary outcome recruit reduced retrieved retrospective cohort study robust RT-PCR SARS-CoV-2 SARS-CoV-2 test shown Sociodemographic characteristics System tested the SARS-CoV-2 the vaccine used data vaccination Vaccine variant variant of SARS-CoV-2 veteran White people [DOI] 10.1016/S2666-7568(22)00166-0 [Article Type] Research article
SARS-CoV-2-specific antibodies and neutralization capacity in breast milk following infection vs vaccinationArticle Published on 2022-09-012022-11-15 Journal: Ultrasound in obstetrics & gynecology : the offici [Category] SARS, 진단, [키워드] acute respiratory syndrome anti-SARS-CoV-2 antibody antibody binding booster dose both groups breast milk changes in children collected convenience sampling coronavirus coronavirus disease COVID-19 COVID-19 vaccine evaluate first dose Gynecology highlight IgA IgA level immunoglobulin A individuals Infection median natural infection neutralization capacity Neutralizing neutralizing antibody peaking Prospective Study rapid increase receive recruited restored SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2-specific antibody secretion Society stimulated study groups the median the vaccine Ultrasound undetectable vaccination Vaccine women [DOI] 10.1002/uog.24965 PMC 바로가기
Efficacy and safety of COVID-19 vaccines: A network meta-analysisArticle Published on 2022-09-012022-11-16 Journal: Journal of evidence-based medicine [Category] meta-analysis, SARS, 변종, [키워드] absence B.1.351 variant clinical trial Community COVID-19 COVID-19 infection COVID-19 vaccines database effective Effectiveness Efficacy effort Human investigated Local Meta-analysis Network meta-analysis nonrandomized pandemic participant Pfizer placebo-controlled clinical trial randomized trial reported required safety profile searched Severe COVID-19 Infection Sinopharm the vaccine threshold trials V-01 vaccination Vaccine variant variants [DOI] 10.1111/jebm.12492 PMC 바로가기
A Review on Immunological Responses to SARS-CoV-2 and Various COVID-19 Vaccine RegimensArticle Published on 2022-09-012022-11-16 Journal: Pharmaceutical research [Category] 변종, [키워드] B cell responses BBIBP-CorV caused clinical trial convalescent convalescent individual convalescent individuals CoronaVac COVID-19 COVID-19 patients COVID-19 vaccine effective effective vaccine Efficacy Efficiency Health immune immune response Immunity Immunological response imperative implementation inactivated investigated long-lasting mechanism NVX-CoV2373 phase Prophylactic regimen regimens Reinfection reported response review RNA SARS-CoV-2 the vaccine transmission of SARS-CoV-2 Vaccine vaccine regimens. Vaccines variant virus [DOI] 10.1007/s11095-022-03323-w PMC 바로가기
An agent-based model to assess large-scale COVID-19 vaccination campaigns for the Italian territory: The case study of Lombardy region이탈리아 영토에 대한 대규모 COVID-19 예방 접종 캠페인을 평가하기 위한 에이전트 기반 모델: 롬바르디아 지역 사례 연구Article Published on 2022-09-012022-09-11 Journal: Computer methods and programs in biomedicine [Category] 변종, [키워드] administration age agency agent agent-based model analyzed approach assigned available dose available doses build calibrated case study concern Covasim COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines cumulative current death deaths Definition dose dynamic early stages Effectiveness Epidemiologic model Free greater group Health Health care Health care worker health care workers help individual individuals Infection infections Italian Italy knowledge lombardy mathematical methodological methodology National nuances parameter priority reduction in Support the vaccine vaccination Vaccine Vaccines variant variants variants of concern [DOI] 10.1016/j.cmpb.2022.107029 PMC 바로가기 [Article Type] Article
Antibody and Memory B-Cell Immunity in a Heterogeneously SARS-CoV-2-Infected and -Vaccinated PopulationArticle Published on 2022-08-302022-11-15 Journal: mBio [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] accumulating acute respiratory syndrome Adenovirus antibody B-cell B.1.1.529 Combination coronavirus correlated country determine distribution elicited FIVE help heterogeneous immune immune evasion immune response Immunity individuals Infection less Level majority memory B memory B cells memory B-cell mRNA Neutralizing Neutralizing activity Neutralizing antibodies neutralizing antibody titers Omicron variant platform Population population immunity prefusion recipient SARS-CoV SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant single vaccine spike trimer the vaccine undetectable vaccination Vaccine [DOI] 10.1128/mbio.00840-22 PMC 바로가기